Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Visen Pharmaceutical HK$783.3 million IPO
The shares are listed on the HKEX
Insulet $450 million senior notes offering
The high-yield notes are due 2033
Caixa Seguridade R$1.2 billion equity offering
The shares are listed on the São Paulo Stock Exchange
AMD $1.5 billion senior notes offering
The investment-grade notes are due 2026 and 2028
QXO $830 million private placement
The shares are traded on the NYSE
Integer Holdings $1 billion convertible senior notes offering
The 1.875% convertible senior notes are due 2030
Canada $3.5 billion global bond offering
The investment-grade bonds are due 2030
Guotai Junan merger with Haitong and concurrent placement of shares
We advised Guotai Junan Securities on the transaction, creating the largest securities company in China
NetApp $1.25 billion notes offering
The investment-grade notes were issued in two tranches
Canadian Pacific Railway $1.2 billion notes offering
The investment-grade notes are due 2030 and 2035